We studied specimens surgically extracted from five eyes of five patients (four men and one woman, 71–79 years of age, mean 75.6 ± 3.1) with PCV. A diagnosis of neovascular AMD was made based on fluorescein angiography (FA) and clinical findings between 2001 and 2003. Although indocyanine green angiography (IGA) showed polypoidal lesions in all five eyes, no typical network vessels were observed. However, PCV was diagnosed based on recently published criteria used to identify PCV
19 and interpret FA findings.
20
Informed consent for the surgical procedure and for the use of excised tissue was obtained from all patients, in accordance with the tenets of the Declaration of Helsinki. Surgical excision of subfoveal CNV was performed according to the method of Lambert et al.
21 The surgical specimens were immediately fixed in 10% formalin in phosphate-buffered solution (pH 7.4) and embedded in paraffin, and 4-μm serial sections were prepared and stained with hematoxylin and eosin (HE), periodic acid-Schiff (PAS) for basement membranes, phosphotungstic acid hematoxylin (PTAH) for fibrin, and elastica van Gieson for elastic fibers.
For immunohistochemical studies, paraffin-embedded sections were deparaffinized, hydrated and rinsed in deionized water. Immunostaining was performed using an automated immunostaining machine (Ventana Medical Systems, Inc. Tucson, AZ) with Endogenous Biotin Blocking Kits (Ventana Medical Systems). The primary antibodies used were as follows. Anti-CD34 antibody (monoclonal mouse anti-human CD34, clone QBEnd-10; 1:20; Dako Cytomation, Carpinteria, CA) was used to confirm blood vessels in the specimens. Anti-α-smooth muscle antibody (Anti-actin, smooth muscle monoclonal clone; 1:15; Thermo Fisher Scientific Inc., Waltham, MA) was used to identify smooth muscle cells and myofibroblasts. Anti-vascular endothelial growth factor (VEGF) antibody (rabbit polyclonal antibody; 1:50; Santa Cruz Biotechnology, Santa Cruz, CA) was used to demonstrate localization of VEGF as an angiogenic factor. Anti-CD68 antibody (mouse monoclonal anti-human macrophage, clone PG-M1; 1:80; Dako Cytomation) was used to identify macrophages. Anti-hypoxia inducible factor (HIF)-1α antibodies (rabbit antibodies; 1:50; Chemicon International, Temecula, CA) were used to examine the oxidative states of tissues. Negative controls were obtained by omitting the primary antibodies. Subsequent reactions with secondary antibodies and visualization were achieved with DAB (DAB Universal Kit; Ventana Medical Systems). The sections were counterstained with hematoxylin and mounted (Permount; Fisher Scientific, Pittsburgh, PA). All the stained slides were evaluated histologically by light microscopy (VANOX-S; Olympus, Tokyo, Japan).